Special Interest Groups

Our special interest groups (SIGs) are a forum for members to discuss topics of mutual interest, keep updated on developments in a particular area of industry, to organise events on their specialist field and/or to collaborate on developing the science of that field. Our current SIGs cover biomarkers, epidemiology and drug safety, health technology assessment and modelling and simulation. We also have a working party looking at the statistical implications of greater clinical trial data sharing and a group of volunteers providing a statistical briefing service on health stories in the lay media.

For further information on any of the SIGs, take a look at their pages on the website using the menu above and contact the chairs.


Latest News


Show all news

EventsFuture Events


  • Expert Working Group on Confidentiality of Interim Results - Dates: 11 May, 2017

    The PSI/EFSPI expert working group on Confidentiality of Interim Results are planning to meet face to face on 11 May.
  • Estimating Sample Sizes in Clinical Trials - Dates: 28 – 29 Jun, 2017

    The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design. The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
Leeds-80x250

Medical Statistician / Senior Medical Statistician

read more...

GSK logo

Director, Statistics

read more...

Astrazeneca

Associate Director, Statistics Team leader - Early Clinical Development

read more...

Astrazeneca

Early Clinical Development – various levels

read more...

LOGO

Biostatistics Head of Department

read more...

Astrazeneca

Principal Statistician – Centralised Statistical Monitoring

read more...

Astrazeneca

Clinical Trial Design Methodology Expert - Statistical Innovation Team

read more...